A prospective, non-interventional multi-center observational study to evaluate the long-term effectiveness and safety of tocilizumab in patients with active rheumatoid arthritis in daily practice

Trial Profile

A prospective, non-interventional multi-center observational study to evaluate the long-term effectiveness and safety of tocilizumab in patients with active rheumatoid arthritis in daily practice

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2017

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms ICHIBAN
  • Sponsors Roche
  • Most Recent Events

    • 17 Jun 2017 Results of interim analysis assessed at week 104 (n=902) presented at the 18th Annual Congress of the European League Against Rheumatism
    • 17 Jun 2017 6th interim analysis results (n=2999 data cut off:Dec 10, 2015) presented at the 18th Annual Congress of the European League Against Rheumatism
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top